Discover open access scientific publications

Search, annotate, share and cite publications

Publications by W Jurczak

Ibrutinib Versus Temsirolimus: 3-Year Follow-Up of Patients With Previously Treated Mantle Cell Lymphoma From the Phase 3, International, Randomized, Open-Label RAY Study

Leukemia

English

Radioimmunotherapy With 90y-Ibritumomab Tiuxetan Is a Safe and Efficient Treatment for Patients With B-Cell Lymphoma Relapsed After Auto-Sct: An Analysis of the International RIT-Network

Bone Marrow Transplantation

Transplantation

Hematology

2010

English

Related publications

Efficacy of Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: A 3-Year Follow-Up Study

Bone Marrow Transplantation

Transplantation

Hematology

2000

English

Radioimmunotherapy for Mantle Cell Lymphoma: 5-Year Follow-Up of 90 Patients From the International RIT Registry

English

Extended Follow-Up and Impact of High-Risk Prognostic Factors From the Phase 3 RESONATE Study in Patients With Previously Treated CLL/SLL

English

Long-Term Follow-Up of the RESONATE™ Phase 3 Trial of Ibrutinib Versus Ofatumumab

English

Eribulin Versus Dacarbazine in Patients With Leiomyosarcoma: Subgroup Analysis From a Phase 3, Open-Label, Randomised Study

British Journal of Cancer

Cancer Research

Oncology

2019

English

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study

Journal of Clinical Oncology

English

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Research and Treatment

Cancer Research

Oncology

2016

English

Combination of Ibrutinib With Rituximab (Ir) Is Highly Effective in Previously Untreated Elderly (>65 Years) Patients (Pts) With Mantle Cell Lymphoma (Mcl) - Phase Ii Trial

Hematological Oncology

English

Laparoscopic Versus Open Surgery for Rectal Cancer: A Meta-Analysis of 3-Year Follow-Up Outcomes

International Journal of Colorectal Disease

Gastroenterology

2016

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by W Jurczak

Ibrutinib Versus Temsirolimus: 3-Year Follow-Up of Patients With Previously Treated Mantle Cell Lymphoma From the Phase 3, International, Randomized, Open-Label RAY Study

Radioimmunotherapy With 90y-Ibritumomab Tiuxetan Is a Safe and Efficient Treatment for Patients With B-Cell Lymphoma Relapsed After Auto-Sct: An Analysis of the International RIT-Network

Related publications

Efficacy of Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: A 3-Year Follow-Up Study

Radioimmunotherapy for Mantle Cell Lymphoma: 5-Year Follow-Up of 90 Patients From the International RIT Registry

Extended Follow-Up and Impact of High-Risk Prognostic Factors From the Phase 3 RESONATE Study in Patients With Previously Treated CLL/SLL

Long-Term Follow-Up of the RESONATE™ Phase 3 Trial of Ibrutinib Versus Ofatumumab

Eribulin Versus Dacarbazine in Patients With Leiomyosarcoma: Subgroup Analysis From a Phase 3, Open-Label, Randomised Study

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Combination of Ibrutinib With Rituximab (Ir) Is Highly Effective in Previously Untreated Elderly (>65 Years) Patients (Pts) With Mantle Cell Lymphoma (Mcl) - Phase Ii Trial

Laparoscopic Versus Open Surgery for Rectal Cancer: A Meta-Analysis of 3-Year Follow-Up Outcomes